Moderna Begins Late-Stage Bird Flu Vaccine Trial in U.S. and U.K.
Moderna has begun a late-stage clinical trial of its experimental bird flu vaccine in the United States and the United Kingdom, marking a significant milestone in the effort to prepare for a possible future influenza pandemic. This is the first pandemic bird flu vaccine built with mRNA technology to reach a late-stage trial, moving the […]
Caterpillar Acquires Electric Tractor Startup Monarch in Bet on Autonomous Agriculture
Caterpillar has acquired Monarch Tractor, a California startup known for building self-driving electric tractors, in a deal that signals the industrial giant’s interest in expanding deeper into agricultural automation and cleaner equipment. The acquisition gives Caterpillar control of a company once viewed as one of the most promising startups in the ag-tech space, especially for […]
Trump’s Research Funding Overhaul Is Reshaping How Universities and Scientists Work With Washington
A major shift in how the Trump administration is approaching federal research funding, with consequences that could reach far beyond universities and laboratories is a core issue that not only covers how much money the government spends on research, but also the rules, priorities, and conditions attached to that support. The administration is trying to […]
Blue Owl Expands Healthcare Real Estate Bet With $2.4 Billion Deal for Sila Realty Trust
Blue Owl Capital has agreed to acquire Sila Realty Trust in an all-cash deal valued at about $2.4 billion, expanding its push into healthcare real estate at a time when alternative asset managers are looking for steadier, income-producing assets.The acquisition will be made through Blue Owl’s real assets division and includes Sila’s portfolio of 137 […]
U.S. Companies Flood New Refund System After Court Orders Return of Illegally Collected Tariffs
A new federal refund system has gone live to let U.S. companies recover money paid under tariffs that were later ruled illegal, triggering a rush of claims from importers eager to reclaim billions of dollars. The portal was launched by U.S. Customs and Border Protection after a court order required the government to prepare to […]
U.S. Factory Output Slips in March as Manufacturing Auto Production Weaken
U.S. manufacturing output declined in March, adding to evidence that the factory sector may be losing momentum after a period of resilience. Apparently, manufacturing production fell 0.3% in March after an upwardly revised 0.9% increase in February. The data suggests that while factories had shown some ability to keep growing earlier in the year, that […]
Uldouz Wallace’s PROTECT Act Advances in Arizona as U.S. and Global Adoption Accelerates
Arizona’s PROTECT Act, introduced by Arizona State Representative Nick Kupper following outreach from Uldouz Wallace, is advancing toward final approval, marking a critical step in addressing the growing global crisis of online exploitation, non-consensual content, and AI-generated deepfake abuse. The legislation has already passed out of the Arizona State House with a bipartisan supermajority and […]
New AWS Platform Aims to Shrink Drug Discovery Timelines From Months to Weeks
Amazon Web Services has launched a new artificial intelligence platform designed to accelerate one of the slowest parts of pharmaceutical research: early-stage drug discovery. The new product, called Amazon Bio Discovery, is meant to help scientists run complex computational workflows without writing code, making advanced AI tools easier to use for researchers who may not […]
Lilly’s New Obesity Pill Wins Approval, but FDA Demands Extra Studies on Liver and Heart Risks
Eli Lilly’s newly approved weight-loss pill has cleared an important regulatory hurdle, but the U.S. Food and Drug Administration is requiring the company to carry out additional safety studies after launch, showing that regulators still want closer scrutiny of the medicine’s risks. Apparently, FDA asked Lilly for more data on possible liver injury linked to […]
Chicago Bears Stadium Fight Shows Why Taxpayer-Funded Sports Deals Often Fail the Public
The fight over where the Chicago Bears should build a new stadium has become more than a regional sports story. Here is a case study in how economic policy often bends toward visible political wins rather than investments that deliver stronger long-term public benefits. The central point is that taxpayers are likely to lose no […]
